Drug product
L-Cysteine Hydrochloride Injection, USP, 50 mg/mL, 50 mL Pharmacy Bulk Package Vials (NDC 66758-005-01), packaged in 5 x 50 mL Vials per carton(NDC 66758-005-02), Rx only, Manufactured for: Sandoz, Inc., Princeton, NJ.
D-0141-2017
Product summary
- Firm
- Sandoz Inc
- Event
- Event 75654
- Status
- Terminated
- Classification
- Class II
- Quantity
- 33,624 vials
- Official record key
drug-enforcement:D-0141-2017
Official wording
Reason: Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that the product sterility may be compromised.
Code information: Lot #: 2070915, 2071015, 2071415, 2071515, 2071615, 2071715, 2072115, 2072215, Exp 07/17; 2092315, 2093015, Exp 09/17; 2100115, Exp 10/17; 2120115, 2120215, Exp 12/17
Distribution pattern: Nationwide throughout the USA
Derived failure modes
-
Sterility assurance
Lack of Assurance of Sterility